AXIM? Biotechnologies Completes Pre-Clinical Drug Studies on New Compound Proving Tenfold Greater Inhibition of Tumor Metastasis Than Parent Compound

SAN DIEGO, March 24, 2020 (GLOBE NEWSWIRE) — AXIM??Biotechnologies, Inc. (OTCQB: AXIM) (?AXIM? Biotech,? ?AXIM? or ?the Company?), an international healthcare solutions com